Table 2.

ORs for the relationship between height and the risk of epithelial ovarian cancer by ovarian cancer type

Height (cm)Adjusted OR* (95% CI)
All cancers (n = 764)All invasive (n = 630)All borderline (n = 134)Invasive serous (n = 342)Invasive endometrioid (n = 148)Invasive mucinous (n = 48)Borderline serous (n = 61)Borderline mucinous (n = 62)
<1601.001.001.001.001.001.001.001.00
160-1641.17 (0.91-1.52)1.11 (0.84-1.46)1.81 (1.08-3.05)1.16 (0.83-1.60)0.99 (0.62-1.57)1.24 (0.60-2.58)0.98 (0.50-1.92)4.52 (1.82-11.18)
165-1690.84 (0.63-1.13)0.87 (0.64-1.18)0.89 (0.49-1.62)0.75 (0.51-1.10)1.12 (0.69-1.84)0.47 (0.17-1.26)0.49 (0.22-1.08)2.10 (0.77-5.74)
170-1741.00 (0.69-1.45)0.89 (0.60-1.32)1.53 (0.80-2.91)0.85 (0.53-1.37)0.97 (0.48-1.93)1.08 (0.40-2.90)0.64 (0.26-1.59)4.67 (1.68-12.96)
≥1751.24 (0.69-2.22)1.28 (0.69-2.40)1.26 (0.47-3.40)1.41 (0.70-2.84)0.86 (0.24-3.12)0.87 (0.17-4.33)0.26 (0.03-2.14)5.27 (1.45-19.08)
Ptrend0.790.660.740.550.930.530.060.021
  • * Adjusted for age (in years), age at menarche (<12, 12, 13, ≥14), weight at age 20 (in kg, <50, 50-<55, 55-<60, ≥60), ever use of oral contraceptives (yes/no), and parity (0, 1-2, 3+).

  • Reference group.